Fathom Therapeutics, formerly Atommap, is a New York-based drug design company combining quantum chemistry, physics-based simulations, and AI to model protein motion at atomic resolution. Its Microcosmos platform generates the data needed to design small molecules with sharper therapeutic effects and reduced off-target risk. The company runs internal discovery programs and discovery partnerships, with a lead asset advanced into animal efficacy studies.
1
Round
4
Tags
Apr 27, 2026
Latest raise
Funding activity · 1 round
Apr 27, 2026
$47M
Series A
Led by Sutter Hill Ventures
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
